Kidney fibrosis is associated with a reduction in the functional renal parenchyma, leading to compromised kidney functions and eventual organ death 1 . There is no effective treatment for renal fibrosis and its occurrence is on the rise 2 . But understanding the complex mechanisms and cellular mediators of kidney fibrosis could offer new therapeutic avenues [3] [4] [5] . To this end, protecting the integrity of the functioning parenchyma is critical for preserving overall tissue function in organ fibrosis. Importantly, a feature of kidney fibrosis includes the transition of TECs into cells with mesenchymal features 4,6-18 , a so-called epithelial-to-mesenchymal transition (EMT). The EMT of TECs has also been observed in human fibrotic kidneys, and enrichment in transcription factors associated with EMT correlates with disease progression [19] [20] [21] . However, the precise contribution of EMT to the progression of kidney fibrosis remains a subject of debate [22] [23] [24] and only a minor population of α−smooth muscle actin (α-SMA) + myofibroblasts are derived from TECs 4 . Induction of expression of the transcriptional regulator of EMT, Snail, in the renal epithelial cells of adult mice is sufficient to provoke expression of mesenchymal features in TECs and results in a marked deposition of interstitial collagen deposition 20 . Yet the functional role of the EMT of injured TECs during renal fibrosis remains unknown. In particular, although repair of injured TECs involves the proliferation of these cells to repopulate the renal tubules with functional epithelia 25, 26 , it remains unclear whether the EMT is directly associated with the cell cycle arrest of these cells, and whether the gain of mesenchymal features by these cells is linked to loss of normal TEC function in the kidney.
RESULTS

Genetic targeting of EMT improves tubular health
To determine the functional significance of the EMT program in renal fibrosis, we bred mice harboring a γGT-Cre locus, which express Cre recombinase specifically in proximal TECs 3 , with mice with LoxP-flanked alleles of Twist1 or Snai1 (Supplementary Fig. 1a) , two transcriptional regulators of the EMT (reviewed in ref. 9 ) that are known to participate in kidney fibrosis 16, 20 . The resulting progeny (γGT-Cre + ;Twist1 loxP/loxP -hereafter referred to as Twist cKO mice, and γGT-Cre + ;Snai1 loxP/loxP -hereafter referred to as Snail cKO mice) were born in accordance with the expected Mendelian ratio. They were fertile and could generate offspring at a normal frequency, reached adulthood without developing any phenotypic abnormalities when compared to litter mates and presented no overt histopathological changes in the kidney or in other organs (Supplementary Fig. 1b,c) . These mice, together with littermate controls (γGT-Cre − ;Twist1 loxP/loxP and γGT-Cre − ;Snai1 loxP/loxP -hereafter referred to as wild-type (WT) or control mice) were subjected to unilateral ureter obstruction (UUO), nephrotoxic serum-induced nephritis (NTN) and folic acid (FA)-induced nephropathy to induce a damaging insult in the renal parenchyma and renal fibrosis 3 . In the UUO model, histopathological analyses revealed no overt changes in heart, lung, liver, pancreas or intestine ( Supplementary Fig. 1d ), whereas analyses of fibrotic kidneys following H&E, MTS (Masson's trichrome staining) and Sirius red staining revealed improved tubular health and a lower degree of interstitial fibrosis in Twist cKO mice compared to WT mice, on day 5 and day 10 after UUO (Fig. 1a-f and Supplementary Fig. 1e ). Levels of interstitial collagen deposition, measured by hydroxyproline release assay, were lower in Twist cKO UUO mouse kidneys than in WT UUO mouse kidneys (Supplementary Fig. 1f ). The lower degree of renal fibrosis in Twist cKO kidneys was associated with a significantly (P < 0.0001) lower presence of α-SMA + myofibroblasts ( Supplementary  Fig. 1g ). Twist1 genetic deletion also correlated with better renal function ( Fig. 1g ) and tubular health, and a lower degree of interstitial fibrosis, in mice that were challenged with NTN ( Supplementary  Fig. 2a ) or FA-induced nephropathy (Supplementary Fig. 2b) compared to their respective littermate controls.
Snail cKO mice (Supplementary Fig. 1a ) that were challenged with UUO or FA also showed better tubular health and renal function, less interstitial fibrosis and a lower number of αSMA + myofibroblasts ( Supplementary Fig. 2c-g) . As anticipated, deletion of Twist1 and Snai1 correlated with a lower frequency of EMT compared to control mice with wild-type Twist1 and Snai1 alleles, observed using lineage tracing of proximal TECs (wherein the γGT promoter drives the Cre-loxP-mediated expression of enhanced yellow fluorescent protein (EYFP), γGT-Cre + ;Twist cKO ;EYFP loxP/+ , γGT-Cre + ;Snail cKO ;EYFP loxP/+ and control γGT-Cre + ;EYFP loxP/+ ) and immunolabeling of the mesenchymal marker α-SMA ( Fig. 1h and Supplementary Fig. 3a,b ) or direct visualization of α-SMA-RFP transgene expression (γGT-Cre + ; Twist cKO ; EYFP loxP/+ ;α-SMA-RFP and control γGT-Cre + ;EYFP loxP/+ ; α-SMA-RFP mice) ( Fig. 1i and Supplementary Fig. 3e ). Analyses of EMT frequency assayed by flow cytometry (E-cadherin + α-SMA + cells) showed a 17.3-24.6% of EMT in fibrotic kidney compared to 12.7% (Twist cKO mice) and 6.2% (Snail cKO mice), or, overall, a 48.2-64.3% decrease of EMT in mice that lacked proximal TEC expression of Twist or Snail, respectively ( Fig. 1j and Supplementary Fig. 3f-h) . Together, these results indicate that EMT suppression in injured TECs suppressed kidney damage and promoted tubular health.
EMT inhibition prevents loss of TEC transporters
In light of the histopathological renoprotective effect that was noted when suppressing Twist1 and Snai1 in TECs of the injured kidney ( Fig. 1 and Supplementary Figs. 1-3) , global gene expression profiling was performed to assay transcriptomic changes in kidneys from Twist cKO , Snail cKO and WT mice in the UUO group and to compare them to contralateral kidneys, as well as to healthy controls of various genotypes ( Fig. 2a,b and Supplementary Fig. 4 ). Although contralateral kidneys from WT mice and healthy kidneys from Twist cKO and Snail cKO mice showed similar transcriptomic signatures to those exhibited by healthy kidneys from WT mice (γGT-Cre − and γGT-Cre + WT) ( Supplementary Fig. 4a,c) , a specific decrease in the expression of genes associated with tubular cell functions was noted when comparing contralateral and diseased kidneys ( Fig. 2a,b and Supplementary Fig. 4b,d ). Such a decrease was attenuated in the fibrotic kidneys of Twist cKO and Snail cKO mice ( Fig. 2a,b and Supplementary Fig. 4b,d ), supporting the observed improved tubular cell function ( Fig. 1 and Supplementary Fig. 2 ). Gene expression analyses and gene set enrichment analysis (GSEA) also confirmed the enrichment for an EMT signature in fibrotic kidneys from WT UUO-treated mice compared to contralateral kidneys and an attenuation of this signature in fibrotic kidneys of Twist cKO and Snail cKO UUO-treated mice ( Supplementary Fig. 4f-h) . In support of the better tubular function in fibrotic kidneys of Twist cKO and Snail cKO UUO-treated mice, GSEA confirmed a strong enrichment for kidneyspecific genes associated with solute transport ( Supplementary  Fig. 4e) , as well as genes associated with fatty acid metabolism and β-oxidation ( Supplementary Fig. 4i ), which were recently demonstrated to be downregulated in fibrotic TECs and associated with cell death and dedifferentiation in TECs in fibrotic kidneys 27 .
Loss of the Na + /K + -ATPase solute transporter in TECs is associated with renal fibrosis 28 , and the loss of organic anion transporter SLC22A6 has been proposed to promote toxic accumulation of metabolites and uremic toxin [29] [30] . Healthy kidneys from Twist cKO and Snail cKO mice showed similar Na + /K + -ATPase, SLC22A6 and AQP1 (aquaporin 1) expression patterns to those of healthy kidneys from WT (γGT-Cre − and γGT-Cre + ) mice ( Supplementary Fig. 5a ). Genetic targeting of Twist1 and Snai1 prevented the dramatic loss in Na + /K + -ATPase, AQP1 and SLC22A6 expression that was noted in the respective fibrotic kidneys from WT mice in all fibrotic models evaluated, including UUO (day 5 and day 10 post UUO, Fig. 6e ,f) models. Transcriptomic and protein expression analyses also corroborated the preserved Na + /K + -ATPase, AQP1 and SLC22A6 expression in fibrotic kidneys from Twist cKO and Snail cKO UUO-treated mice (Supplementary Figs. 6a-d and 7) . Immunological staining showed that TECs undergoing EMT transition (YFP + α-SMA + ) partake in the overall loss of AQP1 expression (with 45.34% of YFP + α-SMA + cells losing AQP1 expression); suppression of EMT in Twist cKO UUO mouse model kidneys reduced the 30.95% loss of AQP1 in YFP + TECs of fibrotic kidneys from WT UUO-treated mice to 18.2% in fibrotic kidneys from Twist cKO UUO-treated mice (Fig. 2i,j and Supplementary Fig. 8 ). Similar findings were noted in fibrotic kidneys from Snail cKO mice compared to fibrotic kidneys from WT npg UUO-treated mice (Supplementary Fig. 9 ). These data support the concept that suppressing the EMT program in TECs preserves tubular AQP1 expression.
EMT reduces TEC transporters in humans with renal fibrosis
We next explored the link between an EMT program and expression of solute and solvent transporters in TECs during the progression of chronic kidney disease in humans. We probed the expression of EMT-related genes and TEC transporters in gene expression data sets (http://www.nephromine.org) from kidney biopsies from humans with kidney fibrosis and TGF-β1-induced EMT of cultured human HK2 TECs (GSE20247, ref. 31) , and performed additional gene expression and functional analyses on humanderived biopsies, human-derived cultured TECs (obtained from humans with diverse fibrotic etiologies; Supplementary Fig. 10a ) and HK2 cells. The EMT signature, including specific expression of TWIST1 and SNAI1, in a cohort of biopsy samples from healthy and fibrotic kidneys, and in the primary TECs isolated from these biopsies, was positively associated with tubulointerstitial fibrosis ( Fig. 3a and Supplementary Fig. 10b ).
Previous studies have demonstrated that decreased expression of the organic anion transporters OAT1 and OAT3 is associated with indoxyl sulfate accumulation, which in turn has been linked to accelerated oxidative stress and renal inflammation in rodents [29] [30] . We assayed expression of OAT1 and OAT3 as well as the amino acid transporter SLC7A9 and the sodium-dependent phosphate transporter SLC34A1, as these transporters were among 16 candidates associated with a decreased glomerular filtration rate and were identified through meta-analysis of genome-wide association study data of cohorts from the Heart and Aging in Genomic Epidemiology and CKDGen consortia 32 and subsequent clustering using known transcriptional networks 33 . Our analyses showed that transcript and protein levels of selected TEC transporters were deregulated in kidney biopsies ( Fig. 3a-e and Supplementary Fig. 10c-f ) from fibrotic kidneys of individuals when compared to healthy kidneys, including the transporter-encoding genes AQP1, ATPB1, SLC22A6 (Fig. 3a) , and ATP1A1, SLC22A4, SLC22A8, SLC16A3, SLC22A1, SLC22A2, SLC22A3, SLC7A9, SLC34A1, SLCO4C1, SLC22A7, whereas SLC22A11, SLC16A9, SLC16A12, and SLC22A13 expression was unchanged ( Supplementary Fig. 10c,d) . ATP1B1, which encodes the β1 essential subunit of the Na + /K + -ATPase pump, and AQP1 are predominantly expressed in TECs, and their relative expression is significantly downregulated in human biopsies with various histology and renal fibrosis ( Fig. 3a-e ). Gene expression analyses also indicate a deregulation of transporter expression in TECs from fibrotic kidneys (samples TEC548 and TEC517) compared to healthy kidneys (samples TEC555 and TEC554), and a specific deregulation in AQP1, ATP1B1, SLC22A6 expression ( Fig. 3f ), as well as in genes encoding other transporters ( Supplementary Fig. 10g ). SLCL7A9, SLCO4C1 and OCTN1 protein levels were also specifically deregulated in fibrotic TECs (Supplementary Fig. 10h ). Supporting the decrease in ATP1B1 transcript levels, the function of the Na + /K + -ATPase pump was reduced in TECs from fibrotic kidneys compared to TECs from healthy kidneys ( Fig. 3g) . Fibrotic TEC changes in transporter transcript, protein and activity levels were associated with an EMT program ( Fig. 3f and Supplementary Fig. 10i ). Similar patterns of gene expression were also noted in the TEC cell line HK2, in which treatment with TGF-β1 results in a robust induction of an EMT program (assayed by gene-expression changes ( Fig. 3h and Supplementary Fig. 11a ), morphological changes, and β-catenin nuclear translocation (Supplementary Fig. 11b)) , with concomitant deregulation in the expression of TEC transporters ( Fig. 3h and Supplementary Fig. 11c,d ) and a significant decrease in Na + /K + -ATPase activity (Fig. 3i) . TGF-β1-induced EMT in HK2 cells was associated with intracellular accumulation of transporterspecific substrates as a result of decreased efflux via organic anion transporter 1 (OAT1, officially known as SLC22A6) and organic ation transporter 3 (OAT3, officially known as SLC22A8) and increased influx via organic cation transporter novel 1 (OCTN1, officially known as SLC22A4) ( Fig. 3j) , supporting the hypothesis that an EMT program induces the loss of TEC transporter functions ( Supplementary Fig. 11f ).
Among the upregulated transporters, MCT4 showed increased expression in fibrotic kidney biopsies ( Supplementary Fig. 10c,e ), consistent with previous reports in which MCT4 was found to be upregulated in several human kidney diseases [34] [35] [36] [37] . MCT4 mediates lactic acid efflux and is associated with lactate accumulation and an acidic microenvironment, both of which are pro-fibrotic stimuli 38, 39 . The upregulation of MCT transporters ( Supplementary Fig. 11c ) in TGF-β1-stimulated HK2 cells was associated with an increase in lactate levels and decreased pH in cell culture media ( Supplementary  Fig. 11e ). In addition, the expression of OCTN1 is associated with chronic inflammatory diseases such as rheumatoid arthritis and Crohn's disease and is directly induced by inflammatory cytokines 40 . A recent study demonstrated that overexpression of SLCO4C1 in transgenic rats reduced accumulation of uremic toxins, ameliorating renal inflammation and interstitial fibrosis 41 . We show that an EMT program in TGF-β1-exposed HK2 cells was associated with decreased SLCO4C1 expression ( Supplementary Fig. 11c ).
Inhibition of the EMT decreases immune infiltration
Inflammation has been widely described as a key driver of kidney fibrosis 42 . Initiated as a protective response to injury, the immune infiltrate evolves and may contribute to fibrotic scarring, leading to the loss of functional parenchyma. Using flow cytometry and immunostaining, we assayed the differential composition of the immune infiltrate in WT and Twist cKO UUO kidneys and compared them to contralateral kidneys and to kidneys from healthy mice. Whereas contralateral and healthy kidneys showed similar immune infiltrate ( Fig. 4a-c) , UUO kidneys showed a significant increase in CD45 + npg leukocyte infiltration (Fig. 4a) . The percentages of CD3 + T cells; both effector (CD4 + Foxp3 − ) and regulator (CD4 + Foxp3 + ) T cells; cytotoxic CD8 + T cells; natural killer cells (NK1.1 + ); gamma delta (γδ + ) T cells; CD11c + dendritic cells; and CD19 + B cells were all significantly increased in fibrotic kidneys compared to contralateral kidneys in WT mice (Fig. 4a) .
In agreement with the histopathological improvement noted in fibrotic kidneys from Twist cKO UUO-treated mice, the fibrosisassociated increase in CD45 + leukocyte infiltration was attenuated when compared to kidneys from WT UUO-treated mice (Fig. 4a) . Specifically, fibrotic kidneys from Twist cKO UUO-treated mice showed a significantly lower degree of T cell (CD4 + Foxp3 − , CD4 + Foxp3 + and cytotoxic CD8 + T cells, except γδ + T cells) as well as CD11c + dendritic cell infiltration compared to that shown by fibrotic kidneys from WT UUO-treated mice, whereas NK and B cells were not changed. Kidney fibrosis was also associated with an influx of macrophages (CD11b + Ly6C − Ly6G − ) and CD11b + Ly6C + and CD11b + Ly6G + myeloid-derived suppressor cells. Fibrotic kidneys from Twist cKO npg UUO-treated mice showed suppressed macrophage infiltration compared to fibrotic kidneys from WT UUO mice (Fig. 4a) . The improved kidney histopathology and renal functions in Twist cKO and Snail cKO mice that were challenged with UUO was thus associated with suppressed recruitment of pro-inflammatory cells. Expression of pro-inflammatory cytokines was higher in fibrotic kidneys from WT UUO-treated mice than in contralateral kidneys, and the expression of cytokine transcripts was lower in fibrotic kidneys from Twist cKO and Snail cKO UUO-treated mice than in fibrotic WT UUO-treated mice (Supplementary Fig. 11g) . Immunolabeling for interstitial CD3 + T cells and F4/80 + macrophages also supported a decrease in T cells when the EMT is suppressed in kidney fibrosis in both Twist cKO and Snail cKO UUO-treated mice (Fig. 4b,c and Supplementary  Fig. 11h,i) . Together, these results suggest that a specific decrease in the EMT program in TECs of fibrotic kidneys leads to improved histopathology associated with suppressed immune infiltration.
EMT arrests TECs in the G2 phase
Chronic kidney disease is associated with inadequate cell cycle progression of the TECs, which arrest in the G2/M phase 25, 26, 43, 44 . TGF-β1 stimulation of mouse TECs also results in a cell cycle arrest at the G2/M phase 45 . We probed whether acquisition of an EMT program in the injured nephron could contribute to G2/M arrest, limiting the regenerative potential of the TECs. Fibrotic kidneys from WT UUO-treated mice exhibited greater phospho-histone H3 (pH3) expression in TECs than did fibrotic kidneys of Twist cKO and Snail cKO UUO-treated mice, as evaluated by flow cytometry (Fig. 5a and Supplementary Fig. 12a,b ) and immunohistochemical analyses ( Fig. 5b and Supplementary Figs. 12c-f and 13) , indicative of a prolonged G2/M phase in the cell cycle. The overall number of proliferating TECs (those that express the proliferation marker Ki67 (Ki67 + )) and cells in the S phase of the cell cycle (those that are BrdU + ) were unchanged in WT, Twist cKO and Snail cKO mice (Supplementary Fig. 12e,f) . These results suggest that the greater number of pH3 + TECs in fibrotic WT kidneys than in Twist cKO and Snail cKO UUO-treated mice probably reflected a prolonged arrest of the TEC cell cycle in the G2/M phase, and suppressing the EMT program relieved this brake. We noted that α−SMA expression is enriched in pH3 + TECs ( Fig. 5b and Supplementary Fig. 13 ), indicating that cells undergoing EMT are delayed in the G2/M phase. These data support the idea that suspension of proliferation of epithelial cells is strongly associated with their acquisition of mesenchymal features through an EMT program. Similar findings were noted in vitro, employing a mouse proximal TEC line (MCT 46 ). An EMT induction using TGF-β1 stimulation, as assayed by gene expression analyses ( Fig. 5c and Supplementary Fig. 14a ), morphological changes ( Fig. 5d ) and β-catenin nuclear accumulation (Fig. 5e) , induced a G2-specific arrest with a characteristic punctate nuclear staining of pH3 + Ki67 + cells (Fig. 5f,g and Supplementary Fig. 14b-e) . The EMTinduced G2 arrest was reversible when EMT induction by TGF-β1 was relieved (24 h off of TGF-β1 after a 24 h period on TGF-β1 stimulation (Fig. 5h-j) ). RNAi-mediated targeting of Twist1 and Snai1 expression (shTwist and shSnail) prevented acquisition of TGF-β1-induced EMT features (Fig. 5d-e and Supplementary Fig. 15a ) and G2 arrest (Fig. 5f,g and Supplementary Fig. 15a ). Overexpression of Twist1 and Snai1 was sufficient to induce Cdkn1a (p21) expression ( Fig. 6a) and G2 arrest (Fig. 6b) . The re-expression (rescue) of Twist1 and Snai1 in MCT shTwist and MCT shSnail, respectively, re-induced a G2 block, supporting the idea that the TGF-β1-induced G2 arrest is indeed mediated by Twist or Snail (Fig. 6c,d and Supplementary   Fig. 15b,c) . Insignificant changes in the proliferation rate of MCT cells-with or without Twist1 suppression-by TGF-β1 stimulation were detected (Supplementary Fig. 15d ). DNA damage was not observed as analyzed by comet assay (Supplementary Fig. 15e ) and TUNEL labeling of kidneys from WT and Twist cKO UUO mice (Supplementary Fig. 15f ).
Overexpression of Snai1 in cultured canine kidney epithelial cells (MDCK cells) induced a cell cycle arrest involving enhanced p21 WAF1/CIP1 expression 46 . Overexpression of Twist1 and Snai1 induced Cdkn1a expression and G2 arrest in MCT cells (Fig. 6a) . Absence of p21 WAF1/CIP1 (using Cdkn1a-knockout mice) improved the progression of kidney disease in the remnant kidney model in association with increased TEC proliferation 47 . Here, the arrest of TGF-β1-treated MCT cells in G2 is concomitant with a higher expression of p21 expression ( Fig. 6e,f) , and RNAi-mediated silencing of p21 prevented TGF-β1-induced G2 arrest (Fig. 6f) , supporting the idea that p21 has a regulatory role in the EMT-induced cell cycle arrest of TECs. Collectively, these results indicate that TGF-β1-mediated induction of an EMT program is associated with a p21-mediated G2 phase cell cycle arrest that requires, at least in part, Twist1 and Snai1, but that is independent of DNA damage-associated cell cycle checkpoint activation.
DISCUSSION
These results provide an opportunity to consider a working model that incorporates an acquired EMT program as a component of the early initiating damage to the functional renal parenchyma (Supplementary Fig. 15g ). It is conceivable that an EMT program observed during early embryogenesis and organ development results in the generation of fully functional mesenchymal cells; in diseases such as organ fibrosis and cancer, however, a complete phenotypic conversion might be rare, with injured epithelial cells exhibiting a more hybrid phenotype with a partial EMT program 18, 48 . Kidneys can encounter many different types of injuries that can damage their TECs. In response to injury, TECs release growth factors, cytokines, chemokines and matrix metalloproteinases (MMPs) to initiate a host repair and regenerative response. Such a response results in vasodilation, basement membrane remodeling and an initial influx of immune cells, such as macrophages 42 . Damaged TECs are vulnerable and experience apoptotic pressure and other stressors, such as macrophagegenerated TGF-β1, among other cytokines 42 . Injury to TECs results in loss of functional parenchyma and induces evasive survival mechanisms, such as an initiation of an EMT program mediated through TGF-β1-induced expression of Twist1 and Snai1 (refs. 9,42) . The EMT program further damages TECs, leading to compromised functional capabilities, generation of a pathological secretome and induction of cell cycle arrest. These events further augment the host injury response, resulting in a robust immune reaction and recruitment of myofibroblasts. Apoptosis and an EMT program of TECs result in a vicious cycle of damage and host response, leading to chronic fibrosis. Preventing the acquisition of an EMT program in injured TECs results in the preservation of functional TECs, a decreased pathological secretome and alleviation of cell cycle arrest, all of which improve organ function 26, 49 . Subsequently, a decrease in myofibroblast recruitment and extracellular matrix deposition also occurs.
Here we show that a fibrotic injury-induced EMT program in TECs leads to a p21-mediated G2 cell cycle arrest, depletion in several TEC solute and solvent transporter genes such as those that encode the Na + /K + -ATPase pump, AQP1, SLC22A6 and anion and cation 1 0 0 8 VOLUME 21 | NUMBER 9 | SEPTEMBER 2015 nAture medicine transporters, among others. TECs undergoing EMT thus emerges with a pronounced G2 cell cycle arrest and deregulated transporter activities. Induced Twist1 or Snai1 expression in TECs is sufficient to induce p21-mediated G2 arrest, and it promotes prolonged TGF-β1-induced cell cycle arrest in G2 phase, limiting the cells' potential for repair and regeneration, and exacerbating chronic fibrosis. Mice with the conditional deletion of EMT-inducing transcription factors, Twist1 or Snai1, in proximal TECs were subjected to kidney fibrosis. Inhibition of an EMT program led to preservation of TEC integrity, restored proliferation and dedifferentiationassociated repair and regeneration, suppressed myofibroblast accumulation, and attenuated fibrosis and immune infiltration. Inhibition of an EMT program in TECs protects functional kidney parenchyma by facilitating cell cycle-dependent repair and regeneration of the fibrotic kidney, informing potential anti-fibrosis therapies.
Our results support the studies of liver fibrosis in which specific deletion of Snai1 in hepatocytes and subsequent induction of carbon tetrachloride-induced liver injury led to attenuation of liver fibrosis 50 . In summary, our experiments offer evidence for the functional relevance and importance of an EMT program in the progression of chronic kidney injury, and they support the notion of targeting the EMT program as a viable therapeutic strategy for protecting functional parenchyma in kidney fibrosis.
METHODS
Methods and any associated references are available in the online version of the paper.
(see Supplementary Fig. 14b ), and number of Ki67 + cells per field of view; the percentage of cells in mitosis (M phase) was calculated as the ratio between the sum of cells in prophase (P), metaphase (M), anaphase (A) and telophase (T) (each phase identified by the unique pattern of phospho-histone H3 staining; see Supplementary Fig. 14b ) and the number of Ki67 + cells per field of view. For the analysis of β-catenin localization, MCT cells adhered to coverslips were fixed with 100% methanol 5 min at −20 °C and then blocked in blocking buffer (0.1% Tween, 1%BSA, 10% normal goat serum, 0.3M glycine in PBS) for 1 h at room temperature before incubation with anti-β-catenin (Abcam, ab16051, 1 µg/ml diluted in 0.1% Tween, 1% BSA PBS) overnight at 4 °C. The following day, cells were incubated with anti-Alexa Fluor 594 anti-rabbit (Invitrogen, 1:250) and with Hoechst for nuclear staining. Representative images were acquired with a Demo Axio Observer.Z1 motorized inverted microscope with an Axiocam 506 monochrome camera and ZEN software (Zeiss). In order for the printed images to accurately represent the quality of the high-resolution screens, the color brightness was modified using Adobe Photoshop and was equally applied across the entire image and equally increased in all the acquired images.
Flow cytometry. For the characterization of immune infiltration, one-quarter of each contralateral and one-quarter of each UUO kidney was minced and allowed to digest in a 2-ml mixture of collagenase (400 U type II collagenase; Worthington) in DMEM medium at 37 °C for 25 min. The tissue lysate was filtered through a 100-nm mesh before immunostaining. The resulting singlecell suspension was stained with fixable viability dye eFluor 780, anti-CD45.2 Pacific Blue, anti-CD3 phycoerythrin (PE)-Cy7, anti-CD3 Alexa Fluor 700, anti-FoxP3 Alexa Fluor 700, anti-CD11c eFluor 615, and anti-NK1.1 PE (all from eBioscience); anti-Granzyme B allophycocyanin (APC) and anti-CD4 Qdot605 (Life Technologies); anti-CD8 Brilliant Violet 650, anti-CD11b BrilliantViolet 570, anti-CD19 Brilliant Violet 650 (all from BioLegend); and anti-Ly6C APC, anti-Ly6G PE-Cy7, and anti-Ki67 FITC (BD Biosciences). The CD45 + cells were analyzed for the expression of the various markers using FlowJo. Doublets were gated out using forward scatter width/height and side-scatter width/height event characteristics.
For EMT and phospho-histone H3 analysis, one-quarter of each contralateral and one-quarter of each UUO kidney was minced and allowed to digest in a 2-ml mixture of collagenase (400 U type II collagenase; Worthington) in DMEM medium at 37 °C for 25 min. The tissue lysate was filtered through a 100-mm mesh before immunostaining. One-fifth of the resulting single-cell suspension was incubated with anti-E-cadherin eFluor660 (eBioscience, 50-3249, 1:100 in PBS-1% BSA) overnight at 4 °C. The following day, cells were washed twice with PBS-1%BSA and then fixed and permeabilized using the Foxp3 staining buffer set (BD Bioscience, 00-5523), according to the manufacturer's instructions. Half of the cells were incubated with anti-α-SMA-Cy3 (Sigma-Aldrich, C6198, 1:100 in permeabilization buffer) or with anti-phospho-histone H3-PE (Cell Signaling, 5764, 1:50 in permeabilization buffer) on ice for 1 h. Finally, cells were washed twice with permeabilization buffer and resuspended in FACS staining buffer (1% FBS, 0.5 mM EDTA PBS).
Protein extraction and western blot analysis. Kidneys were homogenized in RIPA lysis buffer (150 mM NaCl, 50 mM Tris-HCl pH 8, 1% Igepal, 0.5% sodiumdeoxycholate, 0.1% SDS) that was added with a protease inhibitor cocktail (Complete, Roche). Total protein amount was measured with a bicinchoninic acid (BCA) assay (Thermo Scientific) and 20 µg of total lysate for each samples were denatured at 95 °C for 10 min in Laemmli buffer containing β-mercaptoethanol, and then separated in 4-12% Bis-Tris gels (Bolt, Life Technology). The primary antibodies that were used were anti-rabbit AQP1 (Alpha Diagnostic, AQP11-A, 1:500), anti-rabbit Na + K + -ATPase (Cell Signaling, 3010, 1:1,000), anti-rabbit SLC22A6 (Abcam, ab183086, 1:1,000), anti-goat GAPDH (Abcam, ab9483, 1:800) and anti-rabbit vinculin (Abcam, ab18058, 1:10,000).
Hydroxyproline assay. Analysis of collagen content was performed in contralateral and UUO kidneys of WT, Twist cKO and Snail cKO mice by using the hydroxyproline assay kit (Sigma-Aldrich), according to manufacturer instructions. Measurements were normalized to total protein amount.
Gene expression profiling and quantitative real-time PCR analysis. Kidneys were homogenized in TRIzol reagent (Invitrogen) and total RNA was extracted according to the manufacturer's directions, from UUO kidneys and contralateral healthy kidneys in γGT-Cre − ;Twist1 loxP/loxP (WT) and γGT-Cre + ;Twist1 loxP/loxP (Twist cKO ) and in γGT-Cre − ;Snai1 loxP/loxP (WT) and γGT-Cre + ; Snai1 loxP/loxP (Snail cKO ) mice and submitted to the Microarray Core Facility at the M.D. Anderson Cancer Center. Gene expression analysis was performed using MouseRef6 Gene Expression Bead Chip (Illumina). The Limma package from R Bioconductor 52 was used to do quantile normalization of expression arrays and analyze differentially expressed genes between any two sample groups (for example, Twist cKO _UUO versus WT_UUO) (P ≤ 0.05 and fold change ≥ 1.5). Gene set enrichment analysis (GSEA) was used for the analysis of gene pathways/data sets. Gene expression microarray data was deposited in GEO (GSE60685). For real-time PCR analysis in WT, Twist cKO and Snail cKO kidneys total RNA and in MCT and HK2 cells, cDNA synthesis was performed using the Applied Biosystems cDNA synthesis kit according to the manufacturer's directions. Quantitative PCR was performed to analyze the gene expression profiles of the listed genes using SYBR Green PCR Master Mix in a 7300 Sequence Detector System (Applied Biosystems), and measurements were standardized to the expression of the GAPDH housekeeping gene. For Twist1 expression level measurements in MCT cells, RNA from vehicle or TGF-β1-treated MCT shScrbl and shTwist cells was extracted with Pure Link RNA Mini Kit (Ambion) and subjected to the one-step RT-qPCR reaction using SuperScript III Platinum SYBR Green One-Step qRT-PCR kit (Invitrogen), according to manufacturer's instructions. The expression level of Twist1 was normalized to the expression of Gapdh housekeeping gene. The expression data is presented as 1/∆Ct or fold change (2 ∆∆Ct ) with the control group normalized to a fold value of 1. The ∆Ct were used to measure statistical significance in observed changes. Genes and primer sequences are listed below (F: forward, R: reverse primer).
Human genes and primers: ATP1A1 F 5′-ACAGACTTGAGCCGGGGATTA-3′; ATP1A1 R 5′-TCCATTCAGGAGTAGTGGGAG-3′; ATP1B1 F 5′-CCGGTGG CAGTTGGTTTAAGA-3′; ATP1B1 R 5′-GCATCACTTGGATGGTTCCGA-3′; MCT4 F 5′-TACATGTAGACGTGGGTCGC-3′; MCT4 R 5′-CACAAGTT CTCCAGTGCCATT-3′; MCT9 F 5′-CCGTCAGGCGACTTTTT AAG-3′; MCT9 R 5′-CCGGAGGCTTCACAATCTAT-3′; MCT12 F 5′-GGAATGCTG CAGTGTAGCTG-3′; MCT12 R 5′-ATCAGCGCTTGGTGTGGTAT-3′; OAT1 F 5′-GGCAGTCATGCTCACCAGT-3′; OAT1 R 5′-CTGTATCCCACAATGATC CG-3′; OAT2 F 5′-CACACTCCATCCAGCAAGG-3′; OAT2 R 5′-TTG TACCCTACGGTGCTCAG-3′; OAT3 F 5′-GCCATGAAGATAGACTGGGC-3′; OAT3 R 5′-CTGGGTCTACAACAGCACCA-3′; OAT4 F 5′-GAAGATGGT GCTGGTGCC-3′; OAT4 R 5′-CTTTATCTGGGGCCTCCTCT-3′; OAT10 F 5′-GTGGTGTCCTTCAGGTGCTT-3′; OAT10 R 5′-TATGGGCTGGGAAT ATCCTG-3′; SLC7A9 F 5′-CTTTGAGCATGTGACCCTCC-3′; SLC7A9 R 5′-TT TTGTGGCATTTTCAACCA-3′; SLC34A1 F 5′-CCACAAAGATGTGGTTGC AT-3′; SLC34A1 R 5′-GCCACCCAGACTCCTTACAG-3′; OCTN1 F 5′-TA CGAAGAACAGGGAGGTGG-3′ OCTN1 R 5′-GTTCAGCCAGGACGTCT ACC-3′; SLCO4C1 F 5′-CAACTGGTGCTATTCCTTGTTG-3′; SLCO4C1 R 5′-TTGGACTGGGAGCACTTGTA-3′; COL1A2 F 5′-GGTGAAGTGG GTCTTCCAGG-3′; COL1A2 R 5′-TAAGGCCGTTTGCTCCAGG-3′; VIMENTIN F 5′-ATTCCACTTTGCGTTCAAGG-3′; VIMENTIN R 5′-CT TCGAGAGAGGAAGCCGA-3′; S100A4 F 5′-TCTTTCTTGGTTTGATCCTG ACT-3′; S100A4 R 5′-AGTTCTGACTTGTTGAGCTTGA-3′; ACTA2 F 5′-AAGCACAGAGCAAAAGAGGAAT-3′; ACTA2 R 5′-ATGTCGTCCC AGTTGGTGAT-3′; E-CADHERIN F 5′-CATGAGTGTCCCCCGGTATC-3′; E-CADHERIN R 5′-CAGTATCAGCCGCTTTCAGA-3′; TWIST F 5′-CTCA AGAGGTCGTGCCAATC-3′; TWIST R 5′-CCCAGTATTTTTATTTCTAAAGG TGTT-3′; SNAIL F 5′-GGCAATTTAACAATGTCTGAAAAGG-3′; SNAIL R 5′-GAATAGTTCTGGGAGACACATCG-3′; SLUG F 5′-ACTCCGAAGC CAAATGACAA-3′; SLUG R 5′-CTCTCTCTGTGGGTGTGTGT-3′; GAPDH F undisclosed; GAPDH R undisclosed. Mouse genes and primers: TWIST F 5′-CTGCCCTCGGACAAGCTGAG-3′; TWIST R 5′-CTAGTGGGACGCGG ACATGG-3′; SNAIL F 5′-CACACGCTGCCTTGTGTCT-3′; SNAIL R 5′-GG TCAGCAAAAGCACGGTT-3′; GAPDH F 5′-AGGTCGGTGTGAACGGA TTTG-3′; GAPDH R 5′ TGTAGACCATGTAGTTGAGGTCA-3′; CDKN1A F 5′-GTGGCCTTGTCGCTGTCTT-3′; CDKN1A R 5′-GCGCTTGGA npg
